Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Safran

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
American Journal of Clinical Oncology|December 10, 2020
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing RegimensEric I Marks, Robert Matera, Adam J Olszewski, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2002
Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trialHoward Safran, Thomas Dipetrillo, David Iannitti, et al.
Cancer|December 31, 2009
Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trialDamian E Dupuy, Dawei Liu, Donna Hartfeil, et al.
American Journal of Clinical Oncology|December 2, 2014
Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade GliomaJerrold L Boxerman, Benjamin M Ellingson, Suriya Jeyapalan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2016
Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation StudyJaroslaw T Hepel, Kara Lynne Leonard, Howard Safran, et al.
Vaccine|January 29, 2015
Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinomaYoshito Tomimaru, Sasmita Mishra, Howard Safran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411Christopher H Crane, Kathryn Winter, William F Regine, et al.
American Journal of Clinical Oncology|February 8, 2011
Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trialThomas Dipetrillo, Mohan Suntharalingam, Thomas Ng, et al.
International Journal of Hematology|September 3, 2017
Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 studyEric S Winer, Howard Safran, Boguslawa Karaszewska, et al.
American Journal of Clinical Oncology|August 8, 2006
Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I studyTom Dipetrillo, Luka Milas, Devon Evans, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
American Journal of Clinical Oncology|December 10, 2020
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing RegimensEric I Marks, Robert Matera, Adam J Olszewski, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2002
Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trialHoward Safran, Thomas Dipetrillo, David Iannitti, et al.
Cancer|December 31, 2009
Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trialDamian E Dupuy, Dawei Liu, Donna Hartfeil, et al.
American Journal of Clinical Oncology|December 2, 2014
Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade GliomaJerrold L Boxerman, Benjamin M Ellingson, Suriya Jeyapalan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2016
Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation StudyJaroslaw T Hepel, Kara Lynne Leonard, Howard Safran, et al.
Vaccine|January 29, 2015
Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinomaYoshito Tomimaru, Sasmita Mishra, Howard Safran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411Christopher H Crane, Kathryn Winter, William F Regine, et al.
American Journal of Clinical Oncology|February 8, 2011
Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trialThomas Dipetrillo, Mohan Suntharalingam, Thomas Ng, et al.
International Journal of Hematology|September 3, 2017
Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 studyEric S Winer, Howard Safran, Boguslawa Karaszewska, et al.
American Journal of Clinical Oncology|August 8, 2006
Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I studyTom Dipetrillo, Luka Milas, Devon Evans, et al.
Pageof 12